Titan Pharmaceuticals, Inc. (TTNP)
NASDAQ: TTNP · Real-Time Price · USD
4.005
+0.015 (0.37%)
Nov 1, 2024, 4:00 PM EDT - Market closed
Titan Pharmaceuticals Revenue
Titan Pharmaceuticals had revenue of $3.00K in the twelve months ending June 30, 2024, down -99.24% year-over-year. In the year 2023, Titan Pharmaceuticals had annual revenue of $184.00K, down -66.97%.
Revenue (ttm)
$3.00K
Revenue Growth
-99.24%
P/S Ratio
n/a
Revenue / Employee
$750
Employees
4
Market Cap
3.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 184.00K | -373.00K | -66.97% |
Dec 31, 2022 | 557.00K | -969.00K | -63.50% |
Dec 31, 2021 | 1.53M | -3.31M | -68.46% |
Dec 31, 2020 | 4.84M | 2.23M | 85.72% |
Dec 31, 2019 | 2.61M | -4.01M | -60.64% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Novo Integrated Sciences | 13.52M |
MSP Recovery | 7.51M |
Genetic Technologies | 6.45M |
Petros Pharmaceuticals | 4.12M |
Fresh2 Group | 2.34M |
TTNP News
- 2 months ago - TITAN PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Titan Pharmaceuticals, Inc. - TTNP - Business Wire
- 2 months ago - Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. - GlobeNewsWire
- 10 months ago - Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria - GlobeNewsWire
- 11 months ago - Titan Pharmaceuticals Announces Reverse Stock Split and Ratio - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock - GlobeNewsWire
- 1 year ago - Titan Pharmaceuticals Announces Sale of Certain ProNeura Assets - GlobeNewsWire
- 2 years ago - Titan Pharmaceuticals Provides Shareholder Update - GlobeNewsWire